These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 10440623)
1. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs. Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111 [TBL] [Abstract][Full Text] [Related]
3. The upper gastrointestinal safety of rofecoxib vs. NSAIDs: an updated combined analysis. Watson DJ; Yu Q; Bolognese JA; Reicin AS; Simon TJ Curr Med Res Opin; 2004 Oct; 20(10):1539-48. PubMed ID: 15462687 [TBL] [Abstract][Full Text] [Related]
4. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis. Steen KS; Lems WF; Aertsen J; Bezemer D; Dijkmans BA Ann Rheum Dis; 2001 May; 60(5):443-7. PubMed ID: 11302864 [TBL] [Abstract][Full Text] [Related]
5. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Laine L Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):25-32. PubMed ID: 12528071 [TBL] [Abstract][Full Text] [Related]
6. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141 [TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders. La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669 [TBL] [Abstract][Full Text] [Related]
8. Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Graham DY Gastroenterology; 1989 Feb; 96(2 Pt 2 Suppl):675-81. PubMed ID: 2642452 [TBL] [Abstract][Full Text] [Related]
9. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors]. Karateev AE; Nasonova VA Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of etoricoxib versus non-selective NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis patients in the UK. Moore A; Phillips C; Hunsche E; Pellissier J; Crespi S Pharmacoeconomics; 2004; 22(10):643-60. PubMed ID: 15244490 [TBL] [Abstract][Full Text] [Related]
11. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications]. ; Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333 [TBL] [Abstract][Full Text] [Related]
13. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years. Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449 [TBL] [Abstract][Full Text] [Related]
14. Diclofenac/misoprostol: the European clinical experience. McKenna F J Rheumatol Suppl; 1998 May; 51():21-30. PubMed ID: 9596551 [TBL] [Abstract][Full Text] [Related]
15. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Ehsanullah RS; Page MC; Tildesley G; Wood JR BMJ; 1988 Oct; 297(6655):1017-21. PubMed ID: 3142593 [TBL] [Abstract][Full Text] [Related]
16. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Lancaster-Smith MJ; Jaderberg ME; Jackson DA Gut; 1991 Mar; 32(3):252-5. PubMed ID: 2013419 [TBL] [Abstract][Full Text] [Related]
18. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients. Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419 [TBL] [Abstract][Full Text] [Related]
19. Ulcer and bleeding complications and their relationship with dyspeptic symptoms in NSAIDs users: a transversal multicenter study. Dib RA; Chinzon D; Fontes LH; de Sá Teixeira AC; Navarro-Rodriguez T Scand J Gastroenterol; 2014 Jul; 49(7):785-9. PubMed ID: 24941264 [TBL] [Abstract][Full Text] [Related]